Stockreport

BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases [Yahoo! Finan...

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF inform the future clinical trial design for BlueRock's pipeline of cell therapies for treating blindness CAMBRIDGE, MA USA and COLUMBIA, MD, March 25, 2024 (GLOBE NEWS [Read more]